Search

Your search keyword '"Ashfield, Rebecca"' showing total 136 results

Search Constraints

Start Over You searched for: Author "Ashfield, Rebecca" Remove constraint Author: "Ashfield, Rebecca"
136 results on '"Ashfield, Rebecca"'

Search Results

1. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

2. List of contributors

4. Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies

7. Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’

9. Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

10. Production of a high purity, C‐tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions

12. 637 - ARQ-234: a high affinity CD200-Fc fusion protein for the treatment of atopic dermatitis.

13. Global vaccinology training: Report from an ADVAC workshop

15. Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization

16. Monoclonal TCR-redirected tumor cell killing

17. High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation

18. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools

19. Characterisation of factors contributing to the performance of nonwoven fibrous matrices as substrates for adenovirus vectored vaccine stabilisation

20. Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

21. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels

22. Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies

29. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis

30. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

31. Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

32. Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

33. Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system

34. Engineered Gag-specific T-cell Receptors Redirect Polyclonal CD8+ T-cells to Clear HIV-1-infected CD4+ T-cells from ART-treated Patients

35. Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors

37. Abstract 3525: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma

38. Abstract 3528: IMCmage1: A novel bi-specific biologic re-directing T cells to kill MAGE-A3/A6 presenting cancers

40. Abstract 4744: Soluble, high affinity TCRs fused to anti-CD3 redirect T cells to kill cancer cells presenting MAGE-A3 and NY-ESO antigens

41. Abstract 1787: ImmTACs: Bi-functional reagents for redirected tumour cell killing

42. Abstract 5616: Soluble, high affinity TCRs fused to anti-CD3 redirect T cells to kill cancer cells presenting MAGE-A3 and NY-ESO antigens

43. The HLA A*0201–restricted hTERT540–548 peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor

44. High Affinity T Cell Receptors as Therapeutic Agents

50. High affinity soluble ILT2 receptor: a potent inhibitor of CD8+T cell activation

Catalog

Books, media, physical & digital resources